Print Page   |   Contact Us   |   Sign In   |   Join
News and Press: Industry News

The Increasing Demand for R&D Activities to Boost Contract Research Organization Market

Wednesday, September 20, 2017   (0 Comments)
Share |

SOURCE

 

The increase in the number of clinical trials, growing demand for outsourcing clinical trial services and analytical testing, increased outsourcing of R&D activities, and growing R&D expenditure are few of the factors expected to propel the growth of the global market for contract research organization. MarketResearchReports.biz has included a report, “Contract Research Organization Market – Global Deals and Operational Strategies,” which covers various global deals of prominent players and their operational strategies, which are expected to add momentum to the global market over the forthcoming years. This report study sheds light on various deal making activities occurred in the last five years, and presents an in-depth analysis of the prominent deals involving about 40 privately and public held CROs. Furthermore, the operational strategies adopted by companies in the recent years have been formulated. The data exhibited in this report is based on firm utilization and capital management of various key companies. Moreover, profiles and SWOT analysis for the key companies have been included to provide complete comprehension of the market.

Organizations supporting outsourced research services for the medical devices, biotechnology, and pharmaceutical industries are called CROs. Due to the contractual basis of engagement of outsourced services, organizations can efficiently control their expenditure on research and development programs and focus on their core services. A CRO may provide their services for pharmacovigilance, clinical trials management, clinical research, preclinical research, commercialization, biologic assay development, and biopharmaceutical development. In addition, CROs have recently started offering services at all phases, namely labs, phases IIIb & IV, phases II & IIIa, phase I, and pre-clinical, of drug discovery and development. While involving in various collaboration and partnerships, and defining fee structure for service models, CROs have built their capabilities of research from earliest to latest stages of drug development. A significant number of CROs provide only clinical-trial support and clinical-study for medical devices and/or drugs. CROs with expertise in clinical-trials services can offer organizations with the study of any drug or medical device from its origin to FDA/EMA marketing approval. This report includes various trends that are affecting the strategies of the key players in this market.

Along with SWOT analysis and profiles of key players, this report includes vendor positioning, company benchmarking based on heatmap analysis, major acquisitions and partnerships, global deals analysis by type and value, examples of operational strategies, and an overview of key reasons behind outsourcing, outsourcing service models. This market study is fabricated with an extensive market research conducted by top-notch professionals in this domain, to let the market investors strategize their plans to maximize their profits. This study allows readers to understand various operational strategies of key players by analyzing several trends in market deals, licensing, and acquisitions and lets the investors explore potential investment opportunities.

The global contract research organization market can be segmented into key regions such as North America, Europe, and Asia-Pacific. This report covers revenue and growth Leaders, partnerships, service delivery and operational strategies, and deal analysis for these regions are covered in this report. This geographical segmentations is provided to allow readers to understand the regional trends by analyzing the market strategies of companies operating in those regions.

Numerous key players have been taken into consideration for this report. These companies include Jubilant Biosys, Almac Group, Harlan Labs, Sanofi, Pfizer, Avillion, Cromos Pharma, Celonic and PharmaLex, Aurigon, Assign, Protagen, Euprotech, Carlina, BioPharma, Chiltern International, Noble Life Sciences, Sun Pharma, MPI Research, Hangzhou Tigermed, Simbec Research, Eurofins Scientific, Meiji Seika, Consort Medical, Laboratory Corporation of America Holdings, Novotech, Recipharm, EPS Corporation, CMIC Holdings, WuXi PharmaTech, INC Research, Charles River, PRA Health, ICON, Catalent, Parexel, Covance, and Quintiles.


Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal